Trubion Pharmaceuticals Inc.
2401 4th Avenue
Suite 1050
Seattle
Washington
98121
United States
Tel: 206-838-0500
Fax: 206-838-0503
Website: http://www.trubion.com/
88 articles with Trubion Pharmaceuticals Inc.
-
Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals Inc.
10/29/2010
-
Trubion Pharmaceuticals Inc. Announces Early Termination of HSR Waiting Period For Merger With Emergent BioSolutions
9/9/2010
-
Trubion Pharmaceuticals Inc. Reports Second-Quarter and First-Half 2010 Financial Results
8/17/2010
-
Trubion Pharmaceuticals Inc. Announces Dates for Second-Quarter and First-Half 2010 Earnings Conference Call
8/13/2010
-
Emergent BioSolutions To Buy Trubion Pharmaceuticals Inc. For Up To $135.5 Million
8/13/2010
-
Trubion Pharmaceuticals Inc. Says Pfizer Inc. to Stop Development of Arthritis Drug, TRU-015
6/15/2010
-
Trubion Pharmaceuticals Inc. Wins Genentech and Biogen Idec, Inc. (Massachusetts) Patent Appeal
6/4/2010
-
Trubion Pharmaceuticals Inc. to Present at 9th Annual Needham Healthcare Conference
6/2/2010
-
Trubion Pharmaceuticals Inc. Reports First-Quarter 2010 Financial Results
5/7/2010
-
Trubion Pharmaceuticals Inc. Announces Dates for First-Quarter 2010 Earnings Conference Call
4/30/2010
-
Trubion Pharmaceuticals Inc. Announces Dates for First-Quarter 2010 Earnings Conference Call
4/30/2010
-
Trubion Pharmaceuticals Inc. to Present at the BioCentury and Thomson Reuters Future Leaders in the Biotech Industry Conference
4/6/2010
-
Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2009 Financial Results
3/16/2010
-
Trubion Pharmaceuticals Inc. to Present Company Overview and Participate in Panel Discussion at Prestigious Life Science Innovation Northwest 2010
3/12/2010
-
Trubion Pharmaceuticals Inc. Announces Initiation of a Phase 2 Study of SBI-087 for the Treatment of Rheumatoid Arthritis (RA)
1/11/2010
-
Trubion Pharmaceuticals Inc. Announces Upcoming Presentation at OneMedForum 2010
1/7/2010
-
Trubion Pharmaceuticals Inc. and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 American Society of Hematology Annual Meeting
12/8/2009
-
Trubion Pharmaceuticals Inc. CEO Retires
11/17/2009
-
Trubion Pharmaceuticals Inc. Announces Acceptance of Two Presentations on Its TRU-016 Product Candidate at the 2009 American Society of Hematology Annual Meeting
11/12/2009
-
Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2009 Financial Results
11/6/2009